Omicron T cell test under development

Omicron T cell test under development

Following the WHOs announcement about the new SARS-CoV-2 Omicron variant of concern (VoC) on 26 November 2021, the team here at ImmunoServ have started working on a T cell immune response test for this variant. This rapid development demonstrates the flexibility of our T cell testing platform and the dedication of our company to help in the ongoing fight against COVID-19.

Read More

Incorporation

ImmunoServ Lab

We are delighted to announce the incorporation of ImmunoServ Ltd., a specialist contract research organisation in the immunology sector.

Read More